Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. uri icon

authors

  • Kim, Gee Youn Geeny
  • Martin, Mary E
  • Shannon R. McCurdy, MD
  • Perl, Alexander E
  • Porter, David L
  • Schuster, Mindy G
  • Stadtmauer, Edward A
  • Loren, Alison W
  • Burns, Jonathan
  • Freyer, Craig W
  • Hamilton, Keith W
  • Frey, Noelle V
  • Gill, Saar I
  • Hexner, Elizabeth O
  • Luger, Selina M
  • Mangan, James K

publication date

  • May 4, 2020